BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 29, 2026
Home
»
Authors
»
Karen Carey
Articles by Karen Carey
Vical's Asian Partner To Fund Allovectin-7 Phase III Program
May 31, 2006
By
Karen Carey
Years Later: Checking Status Of COR, Aviron Acquisitions
May 31, 2006
By
Karen Carey
Who Wins, Who Loses, Who Overpays In Big-Time M&A
May 30, 2006
By
Karen Carey
Osteologix Gains Listing With Reverse Merger, Raises $10M
May 26, 2006
By
Karen Carey
Avanir Buys Alamo, Gains CNS Product, Sales Force
May 24, 2006
By
Karen Carey
Cruising, Hana Raises $40M For Zensana NDA, Marqibo Studies
May 18, 2006
By
Karen Carey
Viron Raises $25M In Series A For Viral Protein Therapeutics
May 17, 2006
By
Karen Carey
Marshall Edwards Licenses Two Oncology Compounds
May 16, 2006
By
Karen Carey
Osiris Files For $80M IPO; BioMimetic Prices At $37M
May 15, 2006
By
Karen Carey
Diatos In-licensing Gilead's Kaposi's Drug DaunoXome
May 12, 2006
By
Karen Carey
Previous
1
2
…
98
99
100
101
102
103
104
105
106
…
160
161
Next